News & Analysis on Clinical Trial Services & Contract Research And Development
India’s Ministry of Health & Family Welfare will create two new independent committees to oversee policy, guidelines and SOPs (standard operating procedures) for clinical trials, drug approvals and FDCs (fixed-dose combinations).
Following an analysis of its global R&D business Actavis says it will close its Maltese R&D unit at a cost of 60 jobs.
Progenitor Cell Therapy (PCT) has started testing to see if an RNA-based characterization tech developed by Sistemic can improve cell therapy production.
Tokyo-based API Corporation, a unit of Mitsubishi Chemical Holdings Group, is making an investment in API and pharmaceutical manufacturer Neuland Laboratories’ facilities.
Shire has entered the neonatology market by acquiring Premacure and a new therapy and delivery technology designed to treat infant blindness.
Cost competition and the financial crisis have slowed the growth of the global API marker over the past four years according to new data released by the CPA (Italian Chemical Pharmaceutical Association).